Safety and Efficacy Study of Recombinant Human Growth Hormone in Adult Growth Hormone Deficiency Patients

Mise à jour : Il y a 5 ans
Référence : NCT01822340

Femme et Homme

  • | Pays :
  • Hungary
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The purpose of this study is to assess the safety, tolerability and Pharmacokinetic/ Pharmacodynamic (PK/PD) profile of three doses of HM10560A on an every week (EW) regime and one dose on every other week (EOW) regime administered for a period of 24 weeks initial study.


Critère d'inclusion

  • Adult Growth Hormone Deficiency

Liens